Exhibit 5.1
| | | | | | | | |
| | | | 200 Clarendon Street |
| | | | Boston, Massachusetts 02116 |
| | | | Tel: +1.617.948.6000 Fax: +1.617.948.6001 |
| | | | www.lw.com |
| | |
| | | | FIRM / AFFILIATE OFFICES |
| | | | Austin | | Milan | | |
| | | Beijing | | Munich | | |
| | | Boston | | New York | | |
| | | Brussels | | Orange County | | |
| | | Century City | | Paris | | |
| | | | Chicago | | Riyadh | | |
January 31, 2024 | | | | Dubai | | San Diego | | |
| | | | Düsseldorf | | San Francisco | | |
| | | | Frankfurt | | Seoul | | |
| | | | Hamburg | | Silicon Valley | | |
| | | | Hong Kong | | Singapore | | |
| | | | Houston | | Tel Aviv | | |
American Superconductor Corporation | | | | London | | Tokyo | | |
114 East Main Street | | | | Los Angeles | | Washington, D.C. | | |
Ayer, Massachusetts 01432 | | | | Madrid | | | | |
Re: | Registration Statement on Form S-3 (File No. 333-253611); Up to 6,210,000 shares of Common Stock, par value $0.01 per share |
To the addressee set forth above:
We have acted as special counsel to American Superconductor Corporation, a Delaware corporation (the “Company”), in connection with the proposed issuance of up to 6,210,000 shares (the “Shares”) of common stock, $0.01 par value per share (“Common Stock”), including up to 810,000 shares of Common Stock issuable upon exercise of the underwriters’ option to purchase additional shares. The Common Stock is included in a registration statement on Form S-3 under the Securities Act of 1933, as amended (the “Act”), filed with the Securities and Exchange Commission (the “Commission”) on February 26, 2021 (Registration No. 333-253611) (as amended, the “Registration Statement”), a base prospectus dated June 21, 2021 (the “Base Prospectus”) and a prospectus supplement dated January 30, 2024 filed with the Commission pursuant to Rule 424(b) under the Act (together with the Base Prospectus, the “Prospectus”). The Shares are being sold pursuant to an underwriting agreement dated January 30, 2024 between Oppenheimer & Co. Inc., as representative of the several underwriters listed on Schedule A thereto, and the Company (the “Underwriting Agreement”). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the Prospectus, other than as expressly stated herein with respect to the issue of the Shares.
As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the Delaware General Corporation Law (“DGCL”), and we express no opinion with respect to any other laws.